73
Views
91
CrossRef citations to date
0
Altmetric
Article

Hepatic De Novo Lipogenesis Is Present in Liver-Specific ACC1-Deficient Mice

, , , , , , , , , , & show all
Pages 1881-1888 | Received 22 Jun 2006, Accepted 17 Dec 2006, Published online: 27 Mar 2023
 

Abstract

Acetyl coenzyme A (acetyl-CoA) carboxylase (ACC) catalyzes carboxylation of acetyl-CoA to form malonyl-CoA. In mammals, two isozymes exist with distinct physiological roles: cytosolic ACC1 participates in de novo lipogenesis (DNL), and mitochondrial ACC2 is involved in negative regulation of mitochondrial β-oxidation. Since systemic ACC1 null mice were embryonic lethal, to clarify the physiological role of ACC1 in hepatic DNL, we generated the liver-specific ACC1 null mouse by crossbreeding of an Acc1lox(ex46) mouse, in which exon 46 of Acc1 was flanked by two loxP sequences and the liver-specific Cre transgenic mouse. In liver-specific ACC1 null mice, neither hepatic Acc1 mRNA nor protein was detected. However, to compensate for ACC1 function, hepatic ACC2 protein and activity were induced 1.4 and 2.2 times, respectively. Surprisingly, hepatic DNL and malonyl-CoA were maintained at the same physiological levels as in wild-type mice. Furthermore, hepatic DNL was completely inhibited by an ACC1/2 dual inhibitor, 5-tetradecyloxyl-2-furancarboxylic acid. These results strongly demonstrate that malonyl-CoA from ACC2 can access fatty acid synthase and become the substrate for the DNL pathway under the unphysiological circumstances that result with ACC1 disruption. Therefore, there does not appear to be strict compartmentalization of malonyl-CoA from either of the ACC isozymes in the liver.

View correction statement:
Hepatic De Novo Lipogenesis Is Present in Liver-Specific ACC1-Deficient Mice

SUPPLEMENTAL MATERIAL

We thank Yasuko Muramatsu for excellent technical assistance, Jun Suzuki and Yoshiki Itoh for constructive criticism, Akio Kanatani for reviewing the manuscript and offering helpful suggestions, and Toshiyuki Takahashi for synthesizing and providing TOFA (all belong to the Banyu Tsukuba Research Institute). Also we are grateful to Taro Akiyama at Merck Research Laboratories (Rahway, NJ) for providing anti-MCD antibody.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.